Atlanta, GA -- September 9, 2023 A Non-Profit Biotech Model; Therapies for Rare Diseases - Dr. Ashley Winslow By Colabra • Full Transcript • View the Website This episode has two parts. The first part discusses how Odylia Therapeutics is addressing rare disease, using a novel non-profit model....
In 2021, IGI’s Public Impact Team launched a year-long Affordability Task Force (ATF) project aimed at solving one of the trickiest challenges for genomic medicines. The report was released in July 2023 and "is the conclusion of a yearlong deliberation by 30 individuals with expertise...
Odylia and Foundation Fighting Blindness are hosting a 4-part preclinical and translational research webinar series. The series will focus on genetic technologies and will provide advice and educational materials to researchers in the rare disease space. If you are currently working in or thinking about preclinical...